A joint research team led by Prof. Sung Su PARK (Mechanical Engineering) of SKKU and Prof. Sang Hyuk LEE (Dept. of Life Science) of Ehwa Women’s University, developed a technology which can quickly find the cause of the tolerance of anticancer drugs.
Tolerance of anticancer drugs is considered to be the biggest obstacle for curing cancer, due to the lower effectiveness of cancer treatment and to raise the possibility of reoccurrence of the disease. Therefore, finding the cause of the tolerance has always been a popular research topic.
The research team was able to investigate the cause of anticancer drug tolerance via developing a nano chip. By applying this nano chip to brain tumor cell strains, they could induce the tolerance of doxorubicin anticancer drugs and successfully discovered how the tolerance was able to brake out.
“This technology can be applied to various cancers and anticancer drugs” said Prof. PARK. “This technology can the cause of a patients’ tolerance within a short period of time (1 month).”
This project was supported by the Ministry of Trade, Industry and Energy. The results of the study were published in the Proceedings of National Academy of Sciences on Nov 22nd.
List
